These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 1530553

  • 1. Effect of acepromazine, xylazine and thiopentone on factor VIII activity and von Willebrand factor antigen concentration in dogs.
    Mansell PD, Parry BW.
    Aust Vet J; 1992 Aug; 69(8):187-90. PubMed ID: 1530553
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A.
    Stokol T, Trepanier L, Parry BW, Finnin BC.
    Res Vet Sci; 1997 Aug; 63(1):23-7. PubMed ID: 9368952
    [Abstract] [Full Text] [Related]

  • 3. Changes in factor VIII: coagulant activity and von Willebrand factor antigen concentration after subcutaneous injection of desmopressin in dogs with mild hemophilia A.
    Mansell PD, Parry BW.
    J Vet Intern Med; 1991 Aug; 5(3):191-4. PubMed ID: 1920255
    [Abstract] [Full Text] [Related]

  • 4. Changes in factor VIII activity and von Willebrand factor antigen concentration with age in dogs.
    Mansell PD, Parry BW.
    Br Vet J; 1992 Aug; 148(4):329-37. PubMed ID: 1498645
    [Abstract] [Full Text] [Related]

  • 5. Hematological and splenic Doppler ultrasonographic changes in dogs sedated with acepromazine or xylazine.
    Sutil DV, Mattoso CRS, Volpato J, Weinert NC, Costa Á, Antunes RR, Muller TR, Beier SL, Tochetto R, Comassetto F, Saito ME.
    Vet Anaesth Analg; 2017 Jul; 44(4):746-754. PubMed ID: 28756914
    [Abstract] [Full Text] [Related]

  • 6. A bleeding disease (von Willebrand's disease) in a Chesapeake Bay Retriever.
    Johnson GS, Lees GE, Benson RE, Rosborough TK, Dodds WJ.
    J Am Vet Med Assoc; 1980 Jun 01; 176(11):1261-3. PubMed ID: 6776082
    [Abstract] [Full Text] [Related]

  • 7. Haemophilia A in German shepherd dogs.
    Parry BW, Howard MA, Mansell PD, Holloway SA.
    Aust Vet J; 1988 Sep 01; 65(9):276-9. PubMed ID: 3142453
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of fresh-frozen plasma and cryoprecipitate in dogs with von Willebrand's disease or hemophilia A.
    Stokol T, Parry B.
    J Vet Intern Med; 1998 Sep 01; 12(2):84-92. PubMed ID: 9560764
    [Abstract] [Full Text] [Related]

  • 9. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ, Sussman II, Hoyer LW.
    J Clin Invest; 1977 Aug 01; 60(2):390-404. PubMed ID: 17621
    [Abstract] [Full Text] [Related]

  • 10. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
    Zimmerman TS, Voss R, Edgington TS.
    J Clin Invest; 1979 Nov 01; 64(5):1298-302. PubMed ID: 315413
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ristocetin-Willebrand factor activity in dog plasma.
    Johnstone IB, Lotz F.
    Can J Physiol Pharmacol; 1980 Sep 01; 58(9):1128-34. PubMed ID: 6970064
    [Abstract] [Full Text] [Related]

  • 14. Stability of canine factor VIII activity and von Willebrand factor antigen concentration in vitro.
    Mansell PD, Parry BW.
    Res Vet Sci; 1991 Nov 01; 51(3):313-6. PubMed ID: 1780587
    [Abstract] [Full Text] [Related]

  • 15. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y, Simeon J, Caen JP.
    J Lab Clin Med; 1976 Feb 01; 87(2):185-94. PubMed ID: 1082003
    [Abstract] [Full Text] [Related]

  • 16. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
    Mannucci PM, Canciani MT, Rota L, Donovan BS.
    Br J Haematol; 1981 Feb 01; 47(2):283-93. PubMed ID: 6781527
    [Abstract] [Full Text] [Related]

  • 17. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M, Yasui M, Nishino M, Mikami S, Fukui H.
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep 01; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract] [Full Text] [Related]

  • 18. Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.
    Gralnick HR, Coller BS, Sultan Y.
    Science; 1976 Apr 02; 192(4234):56-9. PubMed ID: 1083071
    [Abstract] [Full Text] [Related]

  • 19. Investigations into the effect of two sedatives on the stress response in cattle.
    Brearley JC, Dobson H, Jones RS.
    J Vet Pharmacol Ther; 1990 Dec 02; 13(4):367-77. PubMed ID: 2126805
    [Abstract] [Full Text] [Related]

  • 20. Antibody nature of circulating inhibitor of plasma von Willebrand factor.
    Stratton RD, Wagner RH, Webster WP, Brinkhous KM.
    Proc Natl Acad Sci U S A; 1975 Oct 02; 72(10):4167-71. PubMed ID: 812091
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.